Long term treatment of atrial fibrillation in elderly patients: A decision analysis

International Journal of Cardiology

Volumn 155, Issue 1, 2012, Pages 102-109

  Lafuente Lafuente, Carmelo ^a   Emery, Corinne ^b   Laurendeau, Caroline ^b   Fagnani, Francis ^b   Bergmann, Jean François ^a  

^a HÔPITAL LARIBOISIÈRE   (France)

^b CEMKA EVAL   (France)

Author keywords

Atrial fibrillation; Decision analysis; Older patients; Rate control; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; WARFARIN;

AGE; ARTICLE; COHORT ANALYSIS; DECISION TREE; DISABILITY; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; INTERMETHOD COMPARISON; LONG TERM CARE; LOW DRUG DOSE; MARKOV DECISION ANALYTIC MODEL; MEDICAL DECISION MAKING; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; RISK FACTOR; SENSITIVITY ANALYSIS; SIMULATION; STROKE;

EID: 84859911472     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.130     Document Type: Article

References (26)

1. Heeringa J, van der Kuip DA, Hofman A, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006;27(8):949-53.
2. Wattigney WA, Mensah GA, Croft JB. Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 2003;108(6):711-6.
3. Stewart S, MacIntyre K, MacLeod MM, Bailey AE, Capewell S, McMurray JJ. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J 2001;22(8):693-701.
4. UK National Institute for Health and Clinical Excellence (NICE). Clinical Guidelines: Atrial Fibrillation. http://www.nice.org.uk/Guidance/CG36. Last accessed: 2008 June 10.
5. de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 2005;165(3): 258-62.
6. Testa L, Biondi-Zoccai GG, Russo AD, Bellocci F, Andreotti F, Crea F. Rate control vs rhythm control patients atrial fibrillation metaanalysis. Eur Heart J 2005;26(19): 2000-6.
7. Noheria A, Kumar A, Wylie Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy atrial fibrillation systematic review. Arch Intern Med 2008;168(6): 581-6.
8. van Walraven C, Hart RG, Connolly S, et al. Effect of age on stroke prevention therapy in patients with atrial fibrillation: the atrial fibrillation investigators (AFI). Stroke 2009 Apr;40(4):1410-6.
9. European Heart Survey Investigators, Nieuwlaat R, Capucci A, Camm AJ, et al . Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. Eur Heart J 2005;26(22):2422-34.
10. Somerfield J, Barber PA, Anderson NE, et al. Not all patients with atrial fibrillationassociated ischemic stroke can be started on anticoagulant therapy. Stroke 2006;37(5):1217-20.
11. Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 2007;146(12):857-67.
12. Mant J, Hobbs FD, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370(9586):493-503.
13. Eckman MH, Falk RH, Pauker SG. Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med 1998;158(15):1669-77.
14. Catherwood E, Fitzpatrick WD, Greenberg ML, et al. Cost-effectiveness of cardioversion and antiarrhythmic therapy in nonvalvular atrial fibrillation. Ann Intern Med 1999;130(8):625-36.
15. The A.F.F.I.R.M. and CORE Investigators, Marshall DA, Levy AR, Vidaillet H, et al. Cost effectiveness rhythm versus rate control atrial fibrillation. Ann Intern Med 2004;141(9):653-61.
16. Thomson R, Parkin D, Eccles M, Sudlow M, Robinson A. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Lancet 2000;355(9208):956-62.
17. Desbiens NA. Deciding on anticoagulating the oldest old with atrial fibrillation: insights from cost-effectiveness analysis. J Am Geriatr Soc 2002;50(5):863-9.
18. Man-Son-Hing M, Nichol G, Lau A, Laupacis A. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999;159(7):677-85.
19. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285(22):2864-70.
20. Investigators Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM), Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation (The AFFIRM Study). N Engl J Med 2002;347(23):1825-33.
21. Atrial Fibrillation, Investigators Congestive Heart Failure (AF-CHF), Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008;358(25):2667-77.
22. InstitutNational d'EtudesDémographiques (INED), France. Population en chiffres: Taux de mortalité par sexe et âge en 2005. http://www.ined.fr/fr/pop-chiffres/france/mortalite-causes-deces/ taux-mortalite-sexe-age/. Last accessed: 2009 January 30.
23. van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288(19):2441-8.
24. Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev. 2007;(3): CD006186.
25. Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 2006;119(5):48 e1.19.
26. Coats AJ. Ethical authorship and publishing. Int J Cardiol 2009;131:149-50.